Deutsche Bank Downgrades Ligand Pharmaceuticals To Hold

Analysts at Deutsche Bank downgraded

from Buy to Hold. Ligand Pharmaceuticals shares have gained 44.75 percent over the past 52 weeks, while the S&P 500 index has surged 8.07 percent in the same period. Ligand Pharmaceuticals' shares fell 0.24 percent to close at $93.93 on Friday.